Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Semantic analysis of patient voice in wet AMD and diabetic retinal disease: Patients’ journey and healthcare experience

Author: Olga Zaytseva (Russian Federation)

Co-authors: Vladimir Neroev, Yurii Zhulev, Vera Petrakovskaya, Anna Paleeva, Maria Trifonova, Irina Efimenko

Purpose

The purpose of the study is to analyze Patient Voice (messages from patients with wet age-related macular degeneration (wAMD) and diabetic retinal disease (DRD), or their caregivers) from open Internet resources in the Russian Federation, using artificial intelligence (AI) methods: technologies for automated analysis of unstructured natural language texts, incl. semantic technologies. The study provides valuable information, not only on patients’ characteristics and treatment patterns in real-world management of retinal diseases, but also on patients’ attitude to the disease, diagnostic and treatment-related procedures, their needs and barriers to treatment. The need for such data is explained by the fact that there are no available comprehensive reviews of country-specific patients’ ‘journeys’ assessed from patients’ perspective and analyzed by extracting insights from ‘big data’. Moreover, recent publications show that the healthcare system is ready to recognize such information as an important source of real-world data (RWD). The intensive development of the virtual environment boosted by COVID-19 pandemic also highlighted the responsibility of healthcare stakeholders to develop digital solutions for different groups of patients (apps, remote monitoring tools, web-based platforms, etc.), and it is not achievable without understanding patients’ digital experience, their ‘digital literacy’, attitudes and preferences.

Setting/Venue

Real-life anonymized patient stories from Russian-language open Internet-sources (forums, social networks) were processed with the technologies of natural language understanding (NLU). Patients and caregivers (mainly, relatives) provide direct insights on their journey in diagnostics and treatment in an open and ‘uncensored’ way while looking for a second opinion or exchanging their experience and supporting each other. They use social networks (e.g., Facebook, Instagram, and country-specific networks), disease-related forums, and Q&A portals. There were 73,098 DRD/wAMD-related posts identified including 13,138 posts by 844 DRD patients and 358 posts by 212 wAMD patients.

Methods

The key concept was ‘Patient Voice’ - a source of the patients ‘reality’ which is applied by regulatory bodies (e.g., FDA), pharmaceutical companies, patient advocacy groups, etc. It was analyzed in several steps with semantic technologies aimed at processing large volumes of unstructured information (text semantic analysis considering not keywords, but the whole structure of the natural language and its meaning). 1. Crawling: gathering unstructured data (user posts) from open Web 2.0 sources. After additional filtering based on the system of heuristics (selecting only ‘target’ discussions), plain text data were converted into XML representation. Anonymized patient stories matching the criteria of the ‘diseases of interest’ were selected. 2. Extracting information from each post by NLU algorithms based on hybrid approach to text mining, including pattern-based approach similar to expert systems and machine learning by the Semantic Hub platform. It was driven by the formal domain models called ‘ontologies’ i.e. semantic networks or directed graphs showing the domain concepts and relations between them. Output results were structured in a JSON format, then merged with intelligent algorithms and loaded into a ‘knowledge base’. 3. After unstructured ‘big text data’ were transformed into structured base, traditional biostatistics methods and visualization tools were applied.

Results

Low ‘digital’ awareness and activity of wAMD and DRD patients was detected compared with the diseases with lower prevalence (breast cancer, multiple sclerosis, etc.). The majority of content for DRD was produced by relatives (82.6% of messages), in wAMD - by patients themselves (65%). The key focus for DRD patients was diabetic microvascular manifestations (over 42,000 posts for ‘diabetic foot’ and only 681 for ‘diabetic retinopathy’). Quality of life (QoL) was shown to be significantly affected with inability to work as a major burden for 30% of wAMD patients, and diabetes-associated comorbidities as a key factor compromising QoL in 20% of DRD patients. In wAMD patients mean time-to-diagnosis after disease manifestation was 1 year, in DRD more than a half mentioned 1-2 months. Key reasons for visiting the clinics included in-depth eye exams (OCT mentioned by 27.6% of wAMD patients) and treatment (24.1%) visits. The proportion of DRD patients seeking primary advice of ophthalmologist was higher compared to wAMD (23.3% vs 8.6%). Only 33.2% of wAMD patients and 7% of DRD patients noted that they received anti-VEGFs with affordability as a key barrier mentioned. Patients demonstrated the lack of clear understanding of prognosis and effective treatment options.

Conlusions

The study revealed low activity and awareness in wAMD and DRD patients compared to other ophthalmological and systemic conditions. The awareness on other microvascular diabetic complications in DRD was obviously higher in comparison to other eye disease. This justifies a need for increasing ‘digital’ literacy and awareness not only of patients (it may be challenging due to the age of wAMD patients and their access to digital environment in general) but of their younger relatives as well. The results confirm that vision-related quality of life is compromised among the studied population that could be used for the justification of the appropriate resources allocation in negotiations with health authorities. Based on healthcare experience reported by patients with two vision-threatening retinal diseases it has been demonstrated that there is a need for improvement in at least several points in their ‘journey’ - time-to-diagnosis, treatment choice and availability of effective treatment options. There is also a need to improve patients’ awareness on effective therapeutic options, and efficacy criteria in parallel with improving the access to anti-VEGF therapy.

Financial Disclosure

No

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login